Pharmacological management of Paroxysmal Sympathetic Hyperactivity (PSH): a scoping review.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of neurotrauma"
DOI: 10.1089/neu.2020.7597
Abstract: Paroxysmal sympathetic hyperactivity (PSH) occurs in ~10% of patients following acute severe brain injury. Whilst PSH is associated with worse outcomes there are no clinical practice guidelines to inform treatment. We aimed to systematically review… read more here.
Keywords: psh; hyperactivity psh; case; management ... See more keywords